220 related articles for article (PubMed ID: 31646795)
21. Antidotal or protective effects of Curcuma longa (turmeric) and its active ingredient, curcumin, against natural and chemical toxicities: A review.
Hosseini A; Hosseinzadeh H
Biomed Pharmacother; 2018 Mar; 99():411-421. PubMed ID: 29367110
[TBL] [Abstract][Full Text] [Related]
22. The effects of Curcuma longa and curcumin on reproductive systems.
Mohebbati R; Anaeigoudari A; Khazdair MR
Endocr Regul; 2017 Oct; 51(4):220-228. PubMed ID: 29232190
[TBL] [Abstract][Full Text] [Related]
23. Copper supplementation amplifies the anti-tumor effect of curcumin in oral cancer cells.
Lee HM; Patel V; Shyur LF; Lee WL
Phytomedicine; 2016 Nov; 23(12):1535-1544. PubMed ID: 27765374
[TBL] [Abstract][Full Text] [Related]
24. Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction.
Zheng A; Li H; Wang X; Feng Z; Xu J; Cao K; Zhou B; Wu J; Liu J
Curr Cancer Drug Targets; 2014; 14(2):156-66. PubMed ID: 24274397
[TBL] [Abstract][Full Text] [Related]
25. Preclinical Efficacy of [V4 Q5 ]dDAVP, a Second Generation Vasopressin Analog, on Metastatic Spread and Tumor-Associated Angiogenesis in Colorectal Cancer.
Garona J; Sobol NT; Pifano M; Segatori VI; Gomez DE; Ripoll GV; Alonso DF
Cancer Res Treat; 2019 Apr; 51(2):438-450. PubMed ID: 29879760
[TBL] [Abstract][Full Text] [Related]
26. From medicinal plant extracts to defined chemical compounds targeting the histamine H
Frank A; Abu-Lafi S; Adawi A; Schwed JS; Stark H; Rayan A
Inflamm Res; 2017 Oct; 66(10):923-929. PubMed ID: 28647836
[TBL] [Abstract][Full Text] [Related]
27. Curcumin augments the cytostatic and anti-invasive effects of mitoxantrone on carcinosarcoma cells in vitro.
Luty M; Kwiecień E; Firlej M; Łabędź-Masłowska A; Paw M; Madeja Z; Czyż J
Acta Biochim Pol; 2016; 63(3):397-401. PubMed ID: 27390785
[TBL] [Abstract][Full Text] [Related]
28. The aryl hydrocarbon receptor as an antitumor target of synthetic curcuminoids in colorectal cancer.
Megna BW; Carney PR; Depke MG; Nukaya M; McNally J; Larsen L; Rosengren RJ; Kennedy GD
J Surg Res; 2017 Jun; 213():16-24. PubMed ID: 28601309
[TBL] [Abstract][Full Text] [Related]
29. Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model.
Kunnumakkara AB; Diagaradjane P; Anand P; Harikumar KB; Deorukhkar A; Gelovani J; Guha S; Krishnan S; Aggarwal BB
Int J Cancer; 2009 Nov; 125(9):2187-97. PubMed ID: 19623659
[TBL] [Abstract][Full Text] [Related]
30. Antiproliferative activity and apoptosis-inducing mechanism of Curcuma longa (Turmimax®) on HeLa cell lines.
Firoz HM; Nanjundaiah S; Sadashiva CT; Neethumol B; Rashmi Y; Sreedrisya AK
Braz J Biol; 2023; 83():e275953. PubMed ID: 37820211
[TBL] [Abstract][Full Text] [Related]
31. Oleanolic Acid Inhibits Colorectal Cancer Angiogenesis by Blocking the VEGFR2 Signaling Pathway.
Niu G; Sun L; Pei Y; Wang D
Anticancer Agents Med Chem; 2018; 18(4):583-590. PubMed ID: 29065844
[TBL] [Abstract][Full Text] [Related]
32. Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NFkappaB, cyclinD and MMP-1 transcription.
Liu Q; Loo WT; Sze SC; Tong Y
Phytomedicine; 2009 Oct; 16(10):916-22. PubMed ID: 19524420
[TBL] [Abstract][Full Text] [Related]
33. Multiple biological activities of curcumin: a short review.
Maheshwari RK; Singh AK; Gaddipati J; Srimal RC
Life Sci; 2006 Mar; 78(18):2081-7. PubMed ID: 16413584
[TBL] [Abstract][Full Text] [Related]
34. Antiproliferative effects of an analog of curcumin in Hep-2 cells: a comparative study with curcumin.
Kumaravel M; Sankar P; Latha P; Benson CS; Rukkumani R
Nat Prod Commun; 2013 Feb; 8(2):183-6. PubMed ID: 23513724
[TBL] [Abstract][Full Text] [Related]
35. BMI1 is downregulated by the natural compound curcumin, but not by bisdemethoxycurcumin and dimethoxycurcumin.
Adeyeni TA; Khatwani N; San K; Ezekiel UR
Physiol Rep; 2016 Aug; 4(16):. PubMed ID: 27550987
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of reversal of multidrug resistance by curcumin in human colorectal cancer cell line HCT-8/5-FU.
Fan YX; Abulimiti P; Zhang HL; Zhou YK; Zhu L
Genet Mol Res; 2017 Jun; 16(2):. PubMed ID: 28671249
[TBL] [Abstract][Full Text] [Related]
37. Notoginseng enhances anti-cancer effect of 5-fluorouracil on human colorectal cancer cells.
Wang CZ; Luo X; Zhang B; Song WX; Ni M; Mehendale S; Xie JT; Aung HH; He TC; Yuan CS
Cancer Chemother Pharmacol; 2007 Jun; 60(1):69-79. PubMed ID: 17009031
[TBL] [Abstract][Full Text] [Related]
38. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer.
Mudduluru G; George-William JN; Muppala S; Asangani IA; Kumarswamy R; Nelson LD; Allgayer H
Biosci Rep; 2011 Jun; 31(3):185-97. PubMed ID: 20815812
[TBL] [Abstract][Full Text] [Related]
39. Genistein induces activation of the mitochondrial apoptosis pathway by inhibiting phosphorylation of Akt in colorectal cancer cells.
Qin J; Teng J; Zhu Z; Chen J; Huang WJ
Pharm Biol; 2016; 54(1):74-9. PubMed ID: 25880142
[TBL] [Abstract][Full Text] [Related]
40. Effects of Curcuminoids and Surfactant-Formulated Curcumin on Chemo-Resistant Colorectal Cancer.
Wan C; Ma Q; Anderson S; Zhang QH; Zhang CF; Wang AH; Bell E; Hou L; Yuan CS; Wang CZ
Am J Chin Med; 2023; 51(6):1577-1594. PubMed ID: 37465963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
